GdC_CCCB_lab Profile Banner
Guillermo de Cárcer Profile
Guillermo de Cárcer

@GdC_CCCB_lab

Followers
1K
Following
26K
Media
147
Statuses
9K

Cell Cycle & Cancer Biomarkers lab @IIBmCSICUAM. We #cancerresearch for therapeutic solutions by investigating the #cellcycle and #mitosis.

Madrid, Comunidad de Madrid
Joined June 2020
Don't wanna be here? Send us removal request.
@GdC_CCCB_lab
Guillermo de Cárcer
7 months
Today, February 4th #WorldCancerDay, we present the last paper from the CCCB lab, in the journal #DrugResistanceUpdates. A huge effort, completely from scratch, under the leadership of @AnaMonfVen and #Natalia_Sanz. 🧵(1/11).
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
Ion homeostasis is critical for numerous cellular processes, and disturbances in ionic balance underlie diverse pathological conditions, including cancer progression. Targeting ion homeostasis is...
8
4
27
@GdC_CCCB_lab
Guillermo de Cárcer
2 hours
RT @theBentoLab: If you’re having difficulty making your PCRs both specific and high-yielding, have you heard about touchdown and stepdown….
0
11
0
@grok
Grok
1 day
Join millions who have switched to Grok.
23
26
144
@GdC_CCCB_lab
Guillermo de Cárcer
2 hours
RT @AsimovPress: A few months ago, a paper in Science showed that.cyanobacteria can “sense” shortening days and change the molecular compos….
0
20
0
@GdC_CCCB_lab
Guillermo de Cárcer
6 days
RT @ElizSMcKenna: Now online in @CD_AACR: Integrative Proteogenomics and Forward Genetics Reveals a Novel Mitotic Vulnerability in Triple-N….
0
5
0
@GdC_CCCB_lab
Guillermo de Cárcer
7 days
RT @JCellBiol: Narozna et al. uncover a high-frequency, chromosome 12-specific mis-segregation error in iPSCs. Eroded 12p arms lead to brid….
0
7
0
@GdC_CCCB_lab
Guillermo de Cárcer
7 days
RT @AdrianoAguzzi: Academic scientists complain often about the hardship of their chosen career, but in reality research in academia is amo….
0
115
0
@GdC_CCCB_lab
Guillermo de Cárcer
8 days
RT @ATinyGreenCell: A possible snapgene alternative? Check out vectorbee! .H/t to @JFplantstuff for da heads up.
0
16
0
@GdC_CCCB_lab
Guillermo de Cárcer
9 days
RT @MolecularCell: Tethered to survive: Mitotic transcription secures faithful inheritance of extrachromosomal DNA .
0
18
0
@GdC_CCCB_lab
Guillermo de Cárcer
9 days
RT @omeuxeito: Las #FPI son una de las pocas formas de conseguir un contrato predoctoral sin necesidad de tener unas notas fuera de serie.….
0
10
0
@GdC_CCCB_lab
Guillermo de Cárcer
12 days
RT @joseramosvivas: 🚨Must Read.Solo este mes he rechazado 20 revisiones. Muy lejos de mi récord. 👇🏻..
0
3
0
@GdC_CCCB_lab
Guillermo de Cárcer
12 days
RT @ArkaitzLab: After migrating Cancertool to a new server, we are happy to have it online and available again, wi….
0
8
0
@GdC_CCCB_lab
Guillermo de Cárcer
13 days
RT @salva_iborra: El nuevo modelo de FACs sorter en pleno rendimiento.
0
4
0
@GdC_CCCB_lab
Guillermo de Cárcer
13 days
RT @JuanCarlosLpz13: Are you looking for a postdoc in sunny Madrid? Don’t hesitate and apply for this position at BSainz Lab. Amazing envir….
0
26
0
@GdC_CCCB_lab
Guillermo de Cárcer
13 days
RT @OdedRechavi: Can AI save the day? check out our new tool for pre-submission review (find your paper's weak spots in time!) it's called….
Tweet card summary image
qedscience.com
Critical Thinking AI for constructive criticism and science evaluation
0
40
0
@GdC_CCCB_lab
Guillermo de Cárcer
13 days
RT @NikoMcCarty: HOW TO WEIGH A SINGLE E. COLI. An E. coli cell weighs less than picogram. A grain of sand weighs about 60 million times mo….
0
69
0
@GdC_CCCB_lab
Guillermo de Cárcer
14 days
RT @GenomeIINetwork: 🍂The 2025 Fall Session of GIIN webinars is here! .Join us on the 1st Tuesday of each month at 5 PM CET (Rome) / 11 AM….
0
16
0
@GdC_CCCB_lab
Guillermo de Cárcer
15 days
RT @plopezlarrubia: 👏👏👏.
0
1
0
@GdC_CCCB_lab
Guillermo de Cárcer
15 days
RT @JuanCarlosLpz13: New preprint from the lab. Massive effort by my colleagues at @CNIOStopCancer to tackle RAS inhibitors resistance in P….
0
7
0
@GdC_CCCB_lab
Guillermo de Cárcer
16 days
RT @JSheltzer: Thrilled to share our new paper describing the development and characterization of CDK11 inhibitors for cancer therapy. We a….
0
16
0